Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (2009)

Chapter: 4 Diverse Funding Models

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF.

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter: 3 The Food and Drug Administration's Orphan Drug Program
Page 19 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 19
Page 20 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 20
Page 21 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 21
Page 22 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 22
Page 23 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 23
Page 24 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 24
Page 25 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 25
Page 26 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 26
Page 27 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 27
Page 28 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 28
Page 29 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 29
Page 30 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 30
Page 31 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 31
Page 32 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 32
Page 33 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 33
Page 34 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 34
Page 35 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 35
Page 36 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 36
Page 37 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 37
Page 38 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 38
Page 39 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 39
Page 40 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 40
Page 41 Cite Bookmark
Suggested Citation: "4 Diverse Funding Models." Institute of Medicine. 2009. Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12219.
Save
Cancel
Page 41
Next Chapter: 5 Strategies for Facilitating Sharing of Research Materials and Data
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.